NobleBlocks

From the research index

The paper comes from the research index. It wasn’t submitted here.

Decrease of Neuropsychiatric and Neurocognitive Side Effects Prevalence

Sponsor
Sheba Medical Center
Started
1 May 2015
Trial ID
NCT02447016
View the trial registry

Abstract

The aim of this prospective, open label study is to check for differences in neuropsychiatric and neurocognitive measurements among patients that will be switched from Atripla to Eviplera among 40 patients.

Discussion

Topics

More

Suggest a correction or report